DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Prednylidene

Prednylidene

  • Ep 0173478 A1

    Ep 0173478 A1

  • Pharmaceutical Appendix to the Tariff Schedule 2

    Pharmaceutical Appendix to the Tariff Schedule 2

  • (12) Patent Application Publication (10) Pub. No.: US 2006/0073103 A1 Guck Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2006/0073103 A1 Guck Et Al

  • (12) United States Patent (10) Patent No.: US 7,544,192 B2 Eaton Et Al

    (12) United States Patent (10) Patent No.: US 7,544,192 B2 Eaton Et Al

  • Controlled, Parallel Group Phase 2A Study to Assess the Efficacy of Ro5459072 in Patients with Primary Sjögren’S Syndrome

    Controlled, Parallel Group Phase 2A Study to Assess the Efficacy of Ro5459072 in Patients with Primary Sjögren’S Syndrome

  • WO 2013/020527 Al 14 February 2013 (14.02.2013) P O P C T

    WO 2013/020527 Al 14 February 2013 (14.02.2013) P O P C T

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • Adalimumab for Maintenance of Clinical Response and Remission

    Adalimumab for Maintenance of Clinical Response and Remission

  • United States Patent (10) Patent No.: US 9.447,027 B2 Milan Et Al

    United States Patent (10) Patent No.: US 9.447,027 B2 Milan Et Al

  • Chronic Immune-Mediated Inflammatory Diseases

    Chronic Immune-Mediated Inflammatory Diseases

  • Index Vol. 16-23

    Index Vol. 16-23

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • Transactivation Via the Human Glucocorticoid And

    Transactivation Via the Human Glucocorticoid And

  • Poison Or Antibiotic? a Guide to

    Poison Or Antibiotic? a Guide to "Class" Entries

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • (12) United States Patent (10) Patent No.: US 8,859,774 B2 Hunt Et Al

    (12) United States Patent (10) Patent No.: US 8,859,774 B2 Hunt Et Al

  • (12) United States Patent (10) Patent No.: US 8,080,553 B2 Keith Et Al

    (12) United States Patent (10) Patent No.: US 8,080,553 B2 Keith Et Al

  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort

    NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort

Top View
  • Study Protocol);
  • Ep 1448205 B1
  • (12) United States Patent (10) Patent No.: US 7,368.442 B2 Del Soldato (45) Date of Patent: *May 6, 2008
  • Current Questions and Tentative Answ
  • 210311 Wild Guided Report.Indd
  • Downloaded on September 2, 2021 From
  • Harmonized Tariff Schedule of the United States (2006) (Rev
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
  • (12) United States Patent (10) Patent No.: US 7.253,155 B2 Keith Et Al
  • ICD-10-CM TABLE of DRUGS and CHEMICALS
  • Glucocorticoids for Human Skin: New Aspects of the Mechanism of Action
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • ICD-10-CM Table of Drugs 2019
  • (19) United States (12) Patent Application Publication (10) Pub
  • Ep 0173478 B1


© 2024 Docslib.org    Feedback